Your session is about to expire
← Back to Search
Mentoring Program for At-Risk Teens (FHF-T Trial)
N/A
Waitlist Available
Led By Heather Taussig, PhD
Research Sponsored by University of Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Teens with open child welfare cases placed in foster care, kinship care or living at home
Be younger than 18 years old
Must not have
Moderate or severe developmental delay or physical disability
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (t1), immediately post-intervention (t2) and 15-months-post intervention (t3)
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a mentoring program can help maltreated teenagers in the child welfare system by preventing them from becoming involved in delinquency, substance use, and educational failure.
Who is the study for?
This trial is for 8th or 9th graders with open child welfare cases due to maltreatment, living within a 35-minute radius of the University of Denver. It's not for those with moderate/severe developmental delays or physical disabilities, current or expecting parents, incarcerated youth, or those deemed unsafe for community-based programs.
What is being tested?
The Fostering Healthy Futures for Teens (FHF-T) program is being tested. This mentoring and skills training aims to improve adolescents' relationships, education, activities, career prospects, and health over nine months.
What are the potential side effects?
Since this intervention involves mentoring rather than medical treatment, traditional side effects are not applicable. However, there may be emotional impacts from discussing personal issues during sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a teen in foster care, kinship care, or living at home with an open child welfare case.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a significant developmental delay or physical disability.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (t1), immediately post-intervention (t2) and 15-months-post intervention (t3)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (t1), immediately post-intervention (t2) and 15-months-post intervention (t3)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Court filings for delinquency 15 months-post intervention
Court filings for delinquency immediately post intervention
Passing grades 15 months-post intervention
+7 moreSecondary study objectives
Academic achievement
Conflict management skills
Connectedness to school
+12 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: FHF-T Intervention GroupExperimental Treatment1 Intervention
9 months of 1:1 youth mentoring by graduate-student mentors; workshops; educational advocacy
Group II: Control groupActive Control1 Intervention
Services as usual
Find a Location
Who is running the clinical trial?
University of DenverLead Sponsor
23 Previous Clinical Trials
10,004 Total Patients Enrolled
Heather Taussig, PhDPrincipal InvestigatorUniversity of Denver
Kimberly Bender, PhDPrincipal InvestigatorUniversity of Denver
1 Previous Clinical Trials
244 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are a young person who is currently a parent or will become a parent during the prevention program.I have a significant developmental delay or physical disability.You have a history of severe violent behavior or sexual misconduct.My caseworker thinks I can't safely join a community mentoring program.I am a teen in foster care, kinship care, or living at home with an open child welfare case.
Research Study Groups:
This trial has the following groups:- Group 1: FHF-T Intervention Group
- Group 2: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.